Wow. All right.
I'm going to go back to Dr. Grandvaux for a minute to talk about this concept of consent.
In regard to the decision to delay dosing by four months, you talked about how there isn't data to support that decision, that it has been based on opinion from NACI, and now, I guess, from Health Canada. Can you talk about what that lack of consent means for people in the general public right now, and any potential other negative impacts that we might not have discussed today that Parliament should be concerned with, with the change in that dosing schedule?